Global Coronavirus Vaccine Market Research Report 2023

Publication ID:

PB502240714

Publication Date:

February 14, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Coronavirus vaccines refer to biological products made from coronaviruses for vaccination. It mainly includes inactivated coronavirus vaccine, live attenuated coronavirus vaccine, coronavirus vaccine based on S protein and so on.
Highlights
The global Coronavirus Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Coronavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Coronavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Coronavirus Vaccine in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Coronavirus Vaccine include 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧, 袦芯诲械谤苍邪, 狈芯惫邪惫邪褏, 袪r芯t械褨n 袪芯t械nt褨邪l, 袗濒褉丑邪痴邪褏, 袇褍n邪褨rg械n 袪L小, 狈邪苍芯痴褨谤褨褋褨诲械褧 and 骋骋械苍械小耻谤械, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Coronavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Vaccine.
The Coronavirus Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Coronavirus Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronavirus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧
袦芯诲械谤苍邪
狈芯惫邪惫邪褏
袪r芯t械褨n 袪芯t械nt褨邪l
袗濒褉丑邪痴邪褏
袇褍n邪褨rg械n 袪L小
狈邪苍芯痴褨谤褨褋褨诲械褧
骋骋械苍械小耻谤械
Segment by Type
Coronavirus Inactivated Vaccine
Live Attenuated Coronavirus Vaccine
Coronavirus Vaccine Based On S Protein
Segment by Application
Hospital
Clinic
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Coronavirus Vaccine companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Coronavirus Inactivated Vaccine
1.2.3 Live Attenuated Coronavirus Vaccine
1.2.4 Coronavirus Vaccine Based On S Protein
1.3 Market by Application
1.3.1 Global Coronavirus Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Vaccine Market Perspective (2018-2029)
2.2 Coronavirus Vaccine Growth Trends by Region
2.2.1 Global Coronavirus Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Coronavirus Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Coronavirus Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Coronavirus Vaccine Market Dynamics
2.3.1 Coronavirus Vaccine Industry Trends
2.3.2 Coronavirus Vaccine Market Drivers
2.3.3 Coronavirus Vaccine Market Challenges
2.3.4 Coronavirus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Vaccine Players by Revenue
3.1.1 Global Top Coronavirus Vaccine Players by Revenue (2018-2023)
3.1.2 Global Coronavirus Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Coronavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Coronavirus Vaccine Revenue
3.4 Global Coronavirus Vaccine Market Concentration Ratio
3.4.1 Global Coronavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Vaccine Revenue in 2022
3.5 Coronavirus Vaccine Key Players Head office and Area Served
3.6 Key Players Coronavirus Vaccine Product Solution and Service
3.7 Date of Enter into Coronavirus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Vaccine Breakdown Data by Type
4.1 Global Coronavirus Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Coronavirus Vaccine Forecasted Market Size by Type (2024-2029)
5 Coronavirus Vaccine Breakdown Data by Application
5.1 Global Coronavirus Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Coronavirus Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Coronavirus Vaccine Market Size (2018-2029)
6.2 North America Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Coronavirus Vaccine Market Size by Country (2018-2023)
6.4 North America Coronavirus Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Coronavirus Vaccine Market Size (2018-2029)
7.2 Europe Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Coronavirus Vaccine Market Size by Country (2018-2023)
7.4 Europe Coronavirus Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Coronavirus Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Coronavirus Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Coronavirus Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Coronavirus Vaccine Market Size (2018-2029)
9.2 Latin America Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Coronavirus Vaccine Market Size by Country (2018-2023)
9.4 Latin America Coronavirus Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Coronavirus Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Coronavirus Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧
11.1.1 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧 Company Detail
11.1.2 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧 Business Overview
11.1.3 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧 Coronavirus Vaccine Introduction
11.1.4 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧 Revenue in Coronavirus Vaccine Business (2018-2023)
11.1.5 袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧 Recent Development
11.2 袦芯诲械谤苍邪
11.2.1 袦芯诲械谤苍邪 Company Detail
11.2.2 袦芯诲械谤苍邪 Business Overview
11.2.3 袦芯诲械谤苍邪 Coronavirus Vaccine Introduction
11.2.4 袦芯诲械谤苍邪 Revenue in Coronavirus Vaccine Business (2018-2023)
11.2.5 袦芯诲械谤苍邪 Recent Development
11.3 狈芯惫邪惫邪褏
11.3.1 狈芯惫邪惫邪褏 Company Detail
11.3.2 狈芯惫邪惫邪褏 Business Overview
11.3.3 狈芯惫邪惫邪褏 Coronavirus Vaccine Introduction
11.3.4 狈芯惫邪惫邪褏 Revenue in Coronavirus Vaccine Business (2018-2023)
11.3.5 狈芯惫邪惫邪褏 Recent Development
11.4 袪r芯t械褨n 袪芯t械nt褨邪l
11.4.1 袪r芯t械褨n 袪芯t械nt褨邪l Company Detail
11.4.2 袪r芯t械褨n 袪芯t械nt褨邪l Business Overview
11.4.3 袪r芯t械褨n 袪芯t械nt褨邪l Coronavirus Vaccine Introduction
11.4.4 袪r芯t械褨n 袪芯t械nt褨邪l Revenue in Coronavirus Vaccine Business (2018-2023)
11.4.5 袪r芯t械褨n 袪芯t械nt褨邪l Recent Development
11.5 袗濒褉丑邪痴邪褏
11.5.1 袗濒褉丑邪痴邪褏 Company Detail
11.5.2 袗濒褉丑邪痴邪褏 Business Overview
11.5.3 袗濒褉丑邪痴邪褏 Coronavirus Vaccine Introduction
11.5.4 袗濒褉丑邪痴邪褏 Revenue in Coronavirus Vaccine Business (2018-2023)
11.5.5 袗濒褉丑邪痴邪褏 Recent Development
11.6 袇褍n邪褨rg械n 袪L小
11.6.1 袇褍n邪褨rg械n 袪L小 Company Detail
11.6.2 袇褍n邪褨rg械n 袪L小 Business Overview
11.6.3 袇褍n邪褨rg械n 袪L小 Coronavirus Vaccine Introduction
11.6.4 袇褍n邪褨rg械n 袪L小 Revenue in Coronavirus Vaccine Business (2018-2023)
11.6.5 袇褍n邪褨rg械n 袪L小 Recent Development
11.7 狈邪苍芯痴褨谤褨褋褨诲械褧
11.7.1 狈邪苍芯痴褨谤褨褋褨诲械褧 Company Detail
11.7.2 狈邪苍芯痴褨谤褨褋褨诲械褧 Business Overview
11.7.3 狈邪苍芯痴褨谤褨褋褨诲械褧 Coronavirus Vaccine Introduction
11.7.4 狈邪苍芯痴褨谤褨褋褨诲械褧 Revenue in Coronavirus Vaccine Business (2018-2023)
11.7.5 狈邪苍芯痴褨谤褨褋褨诲械褧 Recent Development
11.8 骋骋械苍械小耻谤械
11.8.1 骋骋械苍械小耻谤械 Company Detail
11.8.2 骋骋械苍械小耻谤械 Business Overview
11.8.3 骋骋械苍械小耻谤械 Coronavirus Vaccine Introduction
11.8.4 骋骋械苍械小耻谤械 Revenue in Coronavirus Vaccine Business (2018-2023)
11.8.5 骋骋械苍械小耻谤械 Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

袉n芯v褨芯袪h邪rm邪褋械ut褨褋邪l褧
袦芯诲械谤苍邪
狈芯惫邪惫邪褏
袪r芯t械褨n 袪芯t械nt褨邪l
袗濒褉丑邪痴邪褏
袇褍n邪褨rg械n 袪L小
狈邪苍芯痴褨谤褨褋褨诲械褧
骋骋械苍械小耻谤械

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂